Nuevolution AB (publ) announces timing for the second quarter release and webcast
Stockholm, 26 January 2016 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its second quarter 2015/16 financial results on Thursday 4 February after the closing of Nasdaq First North Premier. On Friday 5 February at 8:00 CET, the company’s executive management will host a conference call and webcast discussion of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained as follows:
LIVE access on Friday 5 February 2016 at 8:00 CET
SE: +46 85 664 2695
DK: +45 3544 5575
UK: +44 20 3008 9810
US: +1 855 831 5945
Webcast replay will be available on Nuevolution’s website at www.nuevolution.com in the Investors section and at www.financialhearings.com.
Questions may be directed to:
Alex Haahr Gouliaev, CEO, tel.: +45 3913 0902
Henrik Damkjær Simonsen, CFO, tel.: +45 3913 0947
Information about Nuevolution AB (publ)
Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit of patients in need of novel medical treatment option. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology.